Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Visit Radcliffe Cardiology:

AHA 22 - Dr Kate Wilcox, CardioNerds Academic Fellow (Medical College of Wisconsin, US) joins us in this collaboration between the @CardioNerds and Radcliffe Cardiology to interview Dr Jason Andrade (Vancouver General / Montreal Heart Institute, CA), investigator of the late-breaking PROGRESSIVE-AF trial.

The aim of PROGRESSIVE-AF is to assess if the initial treatment choice, cryoballoon-based PVI or anti-arrhythmic drug therapy influences AF disease progression, as measured by continuous cardiac monitoring. The trial showed that first-line ablation was associated with a significantly lower progression to persistent atrial fibrillation when compared to initial anti-arrhythmic drug therapy.

Recorded remotely from Montreal and Wisconsin.

Editor: Mirjam Boros
Video Specialist: Oliver Miles

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Чтобы скачать видео "Radcliffe & CardioNerds @AHA22: The PROGRESSIVE-AF Trial" передвинте ползунок вправо